Botulinum Toxin Type A Injections for Treating Neurogenic Detrusor Overactivity Combined With Low-Compliance Bladder in Patients With Spinal Cord Lesions

Spinal Cord Lesions

Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: A retrospective study of seven cases

Journal of Pediatric Urology ◽

10.1016/j.jpurol.2009.06.001 ◽

2009 ◽

Vol 5 (6) ◽

pp. 430-436 ◽

Cited By ~ 14

Author(s):

C. Do Ngoc Thanh ◽

G. Audry ◽

V. Forin

Keyword(s):

Spinal Cord ◽

Retrospective Study ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Spinal Cord Lesions

AB204. Repeated intradetrusor botulinum toxin type A injections are still effective for patients with neurogenic detrusor overactivity secondary to spinal cord injury in China

Translational Andrology and Urology ◽

10.21037/tau.2016.s204 ◽

2016 ◽

Vol 5 (S1) ◽

pp. AB204-AB204

Author(s):

Hui Chen ◽

Xinghua Yang ◽

Jingwen Zeng ◽

Maping Huang ◽

Qiuling Liu ◽

...

Keyword(s):

Spinal Cord ◽

Spinal Cord Injury ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Cord Injury

Repeated Intradetrusor Botulinum Toxin Type A Injections are Still Effective for Patients with Neurogenic Detrusor Overactivity Secondary to Spinal Cord Injury in China

International Archives of Urology and Complications ◽

10.23937/2469-5742/1510005 ◽

2015 ◽

Vol 1 (1) ◽

Author(s):

Hui Chen

Keyword(s):

Spinal Cord ◽

Spinal Cord Injury ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Cord Injury

Value of Urinary Brain-Derived Neurotrophic Factor Levels on the Assessment of Botulinum Toxin Type A Treatment for Neurogenic Detrusor Overactivity in Children with Myelodysplasia

The Journal of Urology ◽

10.1016/j.juro.2018.06.065 ◽

2019 ◽

Vol 201 (1) ◽

pp. 174-181 ◽

Cited By ~ 3

Author(s):

Cagri Akin Sekerci ◽

Yiloren Tanidir ◽

Tuncay Toprak ◽

Banu Isbilen Basok ◽

Ferruh Isman ◽

...

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Neurotrophic Factor ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Brain Derived Neurotrophic Factor ◽

Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport®) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity

International Urology and Nephrology ◽

10.1007/s11255-009-9528-y ◽

2009 ◽

Vol 41 (4) ◽

pp. 805-813 ◽

Cited By ~ 17

Author(s):

Ibrahim Fathi Ghalayini ◽

Mohammed A. Al-Ghazo ◽

Ziad Ali Elnasser

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Drug Resistant ◽

Dose Dependent

Do Repeat Intradetrusor Botulinum Toxin Type A Injections Yield Valuable Results? Clinical and Urodynamic Results after Five Injections in Patients with Neurogenic Detrusor Overactivity

European Urology ◽

10.1016/j.eururo.2007.08.052 ◽

2007 ◽

Vol 52 (6) ◽

pp. 1729-1735 ◽

Cited By ~ 76

Author(s):

André Reitz ◽

Pierre Denys ◽

Christophe Fermanian ◽

Brigitte Schurch ◽

Eva Comperat ◽

...

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Efficacy and Tolerability of Botulinum Toxin Type A in Patients with Neurogenic Detrusor Overactivity and Without Concomitant Anticholinergic Therapy: Comparison of Two Doses

European Urology ◽

10.1016/j.eururo.2010.06.035 ◽

2010 ◽

Vol 58 (5) ◽

pp. 759-766 ◽

Cited By ~ 33

Author(s):

Philippe Grise ◽

Alain Ruffion ◽

Pierre Denys ◽

Guy Egon ◽

Emmanuel Chartier Kastler

Keyword(s):

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Anticholinergic Therapy

A comparative study between treatment with oxybutynin and botulinum toxin type A in patients with neurogenic detrusor overactivity

http://isrctn.org/> ◽

10.1186/isrctn56769820 ◽

2012 ◽

Author(s):

Ruiter Silva Ferreira

Keyword(s):

Botulinum Toxin ◽

Comparative Study ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

PND8 Cost Reductions Associated With the Use of Botulinum Toxin Type a for the Treatment of Urinary Incontinence in Patients With Neurogenic Detrusor Overactivity

Value in Health ◽

10.1016/j.jval.2012.08.434 ◽

2012 ◽

Vol 15 (7) ◽

pp. A676

Author(s):

J.T. Tan ◽

M. Frost ◽

K. Ng ◽

M. Kirchmann

Keyword(s):

Urinary Incontinence ◽

Botulinum Toxin ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Cost Reductions

Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity

Urology ◽

10.1016/j.urology.2006.08.1069 ◽

2006 ◽

Vol 68 (6) ◽

pp. 1193-1197 ◽

Cited By ~ 75

Author(s):

Gilles Karsenty ◽

André Reitz ◽

Gertraud Lindemann ◽

Sönke Boy ◽

Brigitte Schurch

Keyword(s):

Botulinum Toxin ◽

Therapeutic Effect ◽

Detrusor Overactivity ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽